Policy and Practice
Subscribe
Sign in
Home
Notes
Archive
About
Will Bayesian Statistics Transform Trials?
FDA has finally published its Bayesian guidance. Will it matter?
Published on The Clinical Trials Abundance blog
•
Feb 16
Latest
Top
Discussions
Introducing the Clinical Trials Efficiency Project
To make clinical trials faster and less costly, we need system-level reform
Feb 2
•
Adam Kroetsch
16
14
8
How The FDA Remade Drug Development
My new article in Asterisk Magazine
Dec 23, 2025
•
Adam Kroetsch
15
2
3
FDA is asking for fewer trials. That might be the right call.
How clinical trial progress - and changing economics - made the two-trial standard harder to defend
Dec 11, 2025
•
Adam Kroetsch
16
6
12
Why clinical trials are inefficient. And why it matters.
If we want to accelerate biomedical progress, we need to understand the root causes of clinical trial inefficiency.
Oct 14, 2025
•
Adam Kroetsch
80
15
17
Risk-based regulation is vague regulation
And vague regulation breeds safetyism
Sep 25, 2025
•
Adam Kroetsch
14
1
4
The Badness Police
A Theory of Regulation
Sep 17, 2025
•
Adam Kroetsch
11
1
3
A vision for clinical trial abundance
What does clinical trial abundance look like? And what still stands in our way?
Jul 24, 2025
•
Adam Kroetsch
5
1
See all
Policy and Practice
Exploring innovation in health and medicine, and the institutions, incentives, and infrastructure that drive it.
Subscribe
Policy and Practice
Subscribe
About
Archive
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
